Published in Am J Gastroenterol on September 29, 2015
Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol (2016) 0.79
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci Rep (2016) 0.78
Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn's disease and leprosy. Sci Rep (2016) 0.75
Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis. Gastroenterol Hepatol (N Y) (2016) 0.75
Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review. Clin Rev Allergy Immunol (2017) 0.75
Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis". J Gastroenterol (2016) 0.75
Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases. Diseases (2016) 0.75
Primary biliary cirrhosis. Medicine (Baltimore) (1950) 7.07
Primary biliary cirrhosis. Hepatology (2009) 5.35
Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology (1959) 4.81
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol (2009) 4.45
PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS. Am J Pathol (1965) 2.84
The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology (2008) 2.32
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol (2013) 1.41
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology (2012) 1.38
The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology (2010) 1.16
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol (2015) 1.12
A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology (2012) 1.11
Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol (2015) 1.01
Xanthomatous biliary cirrhosis; a clinical syndrome. Ann Intern Med (1949) 0.94
Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis. Liver Int (2012) 0.90
Genetics and epigenetics of primary biliary cirrhosis. Semin Liver Dis (2014) 0.89
Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis (2014) 0.83
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology (2014) 3.29
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. J Hepatol (2015) 1.52
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'. Gastroenterology (2015) 1.09
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Hepatology (2015) 1.02
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'. Gut (2015) 0.88
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Dig Liver Dis (2015) 0.81
Chronic liver disease questionnaire would be a primary screening tool of neuropsychiatric test detecting minimal hepatic encephalopathy of cirrhotic patients. Hepatol Res (2015) 0.80
Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis. Hepatol Res (2015) 0.79
It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology. Hepatol Res (2016) 0.78
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Clin Res Hepatol Gastroenterol (2015) 0.78
Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int (2016) 0.78
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'. Clin Gastroenterol Hepatol (2015) 0.77
Finding the cure for primary biliary cholangitis - Still waiting. Liver Int (2017) 0.76
Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice. Hepatology (2017) 0.75
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis. Hepatol Res (2014) 0.75
The impact of hepatitis C virus outside the liver: Evidence from Asia. Liver Int (2016) 0.75
Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis? Ann Transl Med (2017) 0.75
Genetic background of primary biliary cirrhosis. Hepatol Res (2007) 0.75
Clinical practice guidelines for the management of children with mother-to-child transmitted hepatitis C virus infection. Pediatr Int (2022) 0.75
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet (2017) 0.75
Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol (2017) 0.75
A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort. J Gastroenterol (2017) 0.75
Machine learning in primary biliary cholangitis: A novel approach for risk stratification. Liver Int (2022) 0.75
Geoepidemiology and changing mortality in primary biliary cholangitis. J Gastroenterol (2017) 0.75
The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol (2016) 0.75
A Randomized Trial of Obeticholic Acid Monotherapy in Patients with Primary Biliary Cholangitis. Hepatology (2017) 0.75